Symphony Neurotech is advancing Low-Intensity Focused Ultrasound (LIFU) as a safe, non-invasive treatment for neurological and psychiatric disorders
Symphony Neurotech is advancing Low-Intensity Focused Ultrasound (LIFU) as a safe, non-invasive treatment for neurological and psychiatric disorders. Led by Dr. Joshua Cain, we're turning a promising technology into a practical clinical platform. Our mission Set the clinical and technical standard for non-invasive neuromodulation, from hospital clinics to at-home solutions. Why LIFU with Symphony Non-invasive alternative to implants: targets deep brain regions without surgery. What we do: Parkinson's focus: large underserved market with ~$5.5B TAM; scalable for patients not responding to meds. Maestro: Easy clinical platform for LIFU brain stimulation: imaging, targeting, personalized treatment. Software includes skull correction, precise targeting, adaptive beamforming, and simple planning. Hardware: Developing advanced closed-loop ultrasound for MRI-free, precise targeting--ultimately, allowing for at-home treatment.